InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Glenn John, 首席财务官. Director active across 2 companies, notably Ekso Bionics Holdings, INC.. Aggregated, 12 reports have been recorded. Breakdown: 0 buy · 4 sells. Total volume traded: €2.1m. History available since 17 February 2022. The latest transaction was filed on 11 December 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
12 条申报中的 12 条
Glenn John is Chief Financial Officer and has filed 12 disclosures in total. In the most recent sampled filings, the period runs from 2022-02-22 to 2026-06-23, with 0 in purchases and 2119654 in sales, and the filings concern Iradimed CORP and Ekso Bionics Holdings, INC.